Position in AMGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$5,656,676
+$315,593 QoQ
Shares Held
15,621
+2.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#777
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $87,152,887 across 10 Drug Manufacturers - General names. AMGN ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,531 | $31,822,079 | |
| 2 | ABBV |
AbbVie Inc.
|
85,535 | $21,524,027 | |
| 3 | JNJ |
Johnson & Johnson
|
43,298 | $10,996,393 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
59,347 | $7,497,899 | |
| 5 | MRK |
Merck & Co., Inc.
|
51,784 | $6,654,244 | |
| 6 | AMGN |
Amgen Inc
This page
|
15,621 | $5,656,676 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,475 | $1,006,909 | |
| 8 | PFE |
Pfizer Inc
|
40,733 | $980,850 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,656,676 | 15,621 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,341,083 | 15,180 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,932,561 | 15,070 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $4,136,769 | 14,659 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $4,108,016 | 14,713 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,817,733 | 12,254 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $865,324 | 3,320 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,034,938 | 3,212 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $484,297 | 1,550 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $420,793 | 1,480 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $421,661 | 1,464 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $391,852 | 1,458 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $308,385 | 1,389 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $348,120 | 1,440 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $378,989 | 1,443 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $370,783 | 1,645 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $367,139 | 1,509 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $246,898 | 1,021 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $463,663 | 2,061 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $383,833 | 1,805 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $210,112 | 862 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $220,445 | 886 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $203,709 | 886 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $5,503,834 | 21,655 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,026,176 | 21,310 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,649,612 | 22,935 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||